A Guide to Private Equity Investment in Health Care


This article written by Wilentz Shareholders Grace Mack and Michael Schaff takes a deep dive into the legal and practical issues that a health care entity would want to consider when weighing a potential private equity investment transaction, including business models, state law restrictions and COVID-19 considerations.

At Wilentz, Grace and Michael co-chair the firm’s prominent health and corporate law practices, advising clients in joint ventures with a variety of healthcare professionals, private equity investments in healthcare, advising start-ups and established businesses on agreements, entity formation and regulatory compliance to purchases or sales and strategic transactions. 

This article was originally published in the August 2021 issue of New Jersey Lawyer, an award-winning publication of the New Jersey State Bar Association, and is reprinted here with permission.

Attachment: A Guide to Private Equity Investment in Health Care

Grace D. Mack Photo

Grace D. Mack
Co-Chair, Health Law Team

Michael F. Schaff Photo

Michael F. Schaff
Co-Chair, Corporate, Health and Cannabis Law Teams